🎙️ On this episode of #BreastCancerBriefing, Sara Nunnery, MD, and @matthewkurianmd.bsky.social discuss the role of AI in breast #oncology. @stelizabethnky.bsky.social #bcsm

👀 Watch the episode on our site or listen on your favorite podcast platform: www.onclive.com/view/oncolog...

Camizestrant plus palbociclib did not significantly improve progression-free survival vs anastrozole plus palbociclib in the first-line SERENA-4 trial. #bcsm #oncology

www.onclive.com/view/serena-...

Now, was that so hard? >>Clinicians should aim to avoid overtreatment when available evidence suggests a less intensive approach may suffice for a lower-risk cancer, and/or the patient is at high risk of serious toxic effects from chemotherapy treatment<<
#bcsm
#patientadvocacy

Hey, who doesn't love a FREE #patient webinar from the National Comprehensive #Cancer Network? Check 'em out, folks! #CanSky #bcsm

* Myeloproliferative Neoplasms (MPN) - Thurs, Sept 24, 2026
* How Biomarker Testing Helps Find the Right Treatment - Mon, Nov 16, 2026

www.nccn.org/patientresou...

On this episode of #BreastCancerBriefing, Sara Nunnery, MD, and Dana Bonaminio, MD, discuss the radiation oncologist's role in breast cancer screening. #bcsm #oncology

Watch the video podcast on our site, or listen on your favorite podcast platforms! www.onclive.com/view/a-breas...

📰 GLP-1s are generating significant buzz for their metabolic benefits, as well as for their potential to directly combat breast cancer progression. #bcsm #oncology

Read insights from Deena Graham, MD, here: www.onclive.com/view/a-new-p...